- Filed
- Mar 17, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Mar 13, 2025 | 16.28M sh |
| Long Term Debt | Q2 2025 · Jan 31, 2025 | $1.14M |
| Long Term Debt | Q2 2025 · Jul 31, 2024 | $1.04M |
| Short Term Debt | Q2 2025 · Jan 31, 2025 | $432.2K |
| Short Term Debt | Q2 2025 · Jul 31, 2024 | $332.59K |
| Stockholders Equity | Q2 2025 · Jan 31, 2025 | $2.73M |
| Stockholders Equity | Q2 2025 · Jul 31, 2024 | $1.16M |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $523.95K |
| Current Liabilities | Q2 2025 · Jul 31, 2024 | $1.57M |
| Total Liabilities | Q2 2025 · Jan 31, 2025 | $1.26M |
| Total Liabilities | Q2 2025 · Jul 31, 2024 | $2.31M |
| Current Assets | Q2 2025 · Jan 31, 2025 | $1.92M |
| Current Assets | Q2 2025 · Jul 31, 2024 | $1.64M |
| Total Assets | Q2 2025 · Jan 31, 2025 | $3.98M |
| Total Assets | Q2 2025 · Jul 31, 2024 | $3.47M |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 2.45M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 1.52M sh |
| Capex restated | Q2 2025 · Jan 31, 2024 | $0 |
| Operating Cash Flow | Q2 2025 · Jan 31, 2024 | −$102.65K |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | −$0.42 |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | −$0.72 |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $4.55K |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $14.36K |
| Net Income restated | Q2 2025 · Jan 31, 2024 | −$1.02M |
| Net Income restated | Q2 2025 · Jan 31, 2024 | −$1.09M |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$60.36K |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$129.68K |
| Revenue | Q2 2025 · Jan 31, 2024 | $13.6K |
| Revenue | Q2 2025 · Jan 31, 2024 | $19.77K |